Literature DB >> 19321754

Epstein-Barr virus protein kinase BGLF4 interacts with viral transactivator BZLF1 and regulates its transactivation activity.

Risa Asai1,2, Ai Kato1, Yasushi Kawaguchi1,2.   

Abstract

BGLF4 is a serine/threonine protein kinase encoded by Epstein-Barr virus. One of the physiological substrates of BGLF4 is viral transactivator BZLF1. In the present study, it was demonstrated that alanine substitution of the serine residue at position 209 (S209A) in BZLF1 eliminated phosphorylation of the protein by BGLF4 in vitro. The S209A mutation in BZLF1, as well as a K102I mutation in BGLF4, which inactivated catalytic activity of the viral kinase, also inhibited formation of a stable BGLF4-BZLF1 complex and downregulation of BZLF1 autotransactivation activity mediated by BGLF4. These results indicate that formation of a stable complex of BGLF4-BZLF1 enables downregulation of BZLF1 autoregulation activity and it appears that BGLF4 phosphorylation of BZLF1 may be involved in these processes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19321754     DOI: 10.1099/vir.0.010462-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  10 in total

1.  Repression of CIITA by the Epstein-Barr virus transcription factor Zta is independent of its dimerization and DNA binding.

Authors:  Nicolae Balan; Kay Osborn; Alison J Sinclair
Journal:  J Gen Virol       Date:  2015-12-11       Impact factor: 3.891

2.  Sumoylation of the Epstein-Barr virus BZLF1 protein inhibits its transcriptional activity and is regulated by the virus-encoded protein kinase.

Authors:  Stacy R Hagemeier; Sarah J Dickerson; Qiao Meng; Xianming Yu; Janet E Mertz; Shannon C Kenney
Journal:  J Virol       Date:  2010-02-24       Impact factor: 5.103

3.  Herpes simplex virus 1 protein kinase Us3 and major tegument protein UL47 reciprocally regulate their subcellular localization in infected cells.

Authors:  Akihisa Kato; Zhuoming Liu; Atsuko Minowa; Takahiko Imai; Michiko Tanaka; Ken Sugimoto; Yukihiro Nishiyama; Jun Arii; Yasushi Kawaguchi
Journal:  J Virol       Date:  2011-07-06       Impact factor: 5.103

4.  SUMO binding by the Epstein-Barr virus protein kinase BGLF4 is crucial for BGLF4 function.

Authors:  Renfeng Li; Leyao Wang; Gangling Liao; Catherine M Guzzo; Michael J Matunis; Heng Zhu; S Diane Hayward
Journal:  J Virol       Date:  2012-03-07       Impact factor: 5.103

5.  Simian virus 40 T/t antigens and lamin A/C small interfering RNA rescue the phenotype of an Epstein-Barr virus protein kinase (BGLF4) mutant.

Authors:  Qiao Meng; Stacy R Hagemeier; Chad V Kuny; Robert F Kalejta; Shannon C Kenney
Journal:  J Virol       Date:  2010-02-10       Impact factor: 5.103

6.  Regulation of microtubule dynamics through phosphorylation on stathmin by Epstein-Barr virus kinase BGLF4.

Authors:  Po-Wen Chen; Sue-Jane Lin; Shu-Chun Tsai; Jiun-Han Lin; Mei-Ru Chen; Jiin-Tarng Wang; Chung-Pei Lee; Ching-Hwa Tsai
Journal:  J Biol Chem       Date:  2010-01-28       Impact factor: 5.157

7.  Key motifs in EBV (Epstein-Barr virus)-encoded protein kinase for phosphorylation activity and nuclear localization.

Authors:  Svetlana Gershburg; Leann Murphy; Manfred Marschall; Edward Gershburg
Journal:  Biochem J       Date:  2010-10-15       Impact factor: 3.857

8.  Transcriptional repression by sumoylation of Epstein-Barr virus BZLF1 protein correlates with association of histone deacetylase.

Authors:  Takayuki Murata; Naoe Hotta; Shigenori Toyama; Sanae Nakayama; Shigeki Chiba; Hiroki Isomura; Takayuki Ohshima; Teru Kanda; Tatsuya Tsurumi
Journal:  J Biol Chem       Date:  2010-06-01       Impact factor: 5.157

Review 9.  Conquering the Nuclear Envelope Barriers by EBV Lytic Replication.

Authors:  Chung-Pei Lee; Mei-Ru Chen
Journal:  Viruses       Date:  2021-04-18       Impact factor: 5.048

10.  A locus encompassing the Epstein-Barr virus bglf4 kinase regulates expression of genes encoding viral structural proteins.

Authors:  Ayman El-Guindy; Francesc Lopez-Giraldez; Henri-Jacques Delecluse; Jessica McKenzie; George Miller
Journal:  PLoS Pathog       Date:  2014-08-28       Impact factor: 6.823

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.